{
  "paper_metadata": {
    "pmid": "25923920",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted variants in the BRCA2 gene, including a novel frameshift mutation and other rare variants, along with penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.-/AC",
      "protein_notation": "p.Thr363fs",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 1,
        "demographics": "female, Saudi Arabian",
        "phenotype": "breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "We have identified one novel frameshift mutation affecting BRCA2 caused by an -/AC insertion affecting one patient only."
        }
      ],
      "functional_data": {
        "summary": "The frameshift mutation is expected to lead to a truncated and presumably dysfunctional protein.",
        "assays": []
      },
      "segregation_data": "Segregated with disease in the family.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This is the first report on the breast cancer predisposition factors in the population of the Kingdom of Saudi Arabia.",
      "key_quotes": [
        "We have identified a novel insertion that led to a frameshift mutation (p.Thr363fs) in BRCA2 causing the synthesis of a truncated and presumably dysfunctional protein."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.7472C>T",
      "protein_notation": "p.Arg2494Stop",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "female, Saudi Arabian",
        "phenotype": "breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "We have identified another rare mutation in BRCA2 in one of our patients. Represented by the rs80358972 SNP, the p.Arg2494Stop affecting BRCA2 has been reported by the Breast Cancer Information Core."
        }
      ],
      "functional_data": {
        "summary": "The nonsense mutation is expected to result in a truncated protein.",
        "assays": []
      },
      "segregation_data": "Segregated with disease in the family.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This variant has been reported by the Breast Cancer Information Core submitted by Myriad Genetics.",
      "key_quotes": [
        "We have identified another rare mutation in BRCA2 in one of our patients. Represented by the rs80358972 SNP, the p.Arg2494Stop affecting BRCA2 has been reported by the Breast Cancer Information Core."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.1067A>G",
      "protein_notation": "p.Gln356Arg",
      "genomic_position": null,
      "clinical_significance": "VUS",
      "patients": {
        "count": 7,
        "demographics": "female, Saudi Arabian",
        "phenotype": "breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 7,
        "affected_count": 7,
        "unaffected_count": 0,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "We observed an increase in the number of breast cancer cases displaying the homozygous GG minor allele state that is not seen in the control cases."
        }
      ],
      "functional_data": {
        "summary": "The clinical significance of this variant remains uncertain.",
        "assays": []
      },
      "segregation_data": "Not specified.",
      "population_frequency": "MAF of 0.058 in the cohort.",
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The minor allele frequency of the rs1799950 SNP did not differ significantly from controls.",
      "key_quotes": [
        "We observed an increase in the number of breast cancer cases displaying the homozygous GG minor allele state that is not seen in the control cases."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 3,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant BRCA2 variants were extracted with detailed penetrance data."
  }
}